Browsing by Subject Infliximab
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
| 2014 | Dose optimization is effective in ulcerative colitis patients losing response to infliximab : a collaborative multicentre retrospective study | Cesarini, Monica; Katsanos, Konstantinos; Papamichael, Konstantinos; Ellul, Pierre; Lakatos, Peter L.; Caprioli, Flavio; Kopylov, Uri; Tsianos, Epameinondas; Mantzaris, Gerassimos J.; Ben-Horin, Shomron; Danese, Silvio; Fiorino, Gionata |
| 2012 | Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response | Katz, Lior; Gisbert, Javier P.; Manoogian, Beth; Lin, Kirk; Steenholdt, Casper; Mantzaris, Gerassimos J.; Atreja, Ashish; Ron, Yulia; Swaminath, Arun; Shah, Somal; Hart, Ailsa; Lakatos, Peter Laszlo; Ellul, Pierre; Israeli, Eran; Svendsen, Mads Naundrup; van der Woude, C. Janneke; Katsanos, Konstantinos H.; Yun, Laura; Tsianos, Epameinondas V.; Nathan, Torben; Abreu, Maria; Dotan, Iris; Lashner, Bret; Brynskov, Jorn; Terdiman, Jonathan P.; Higgins, Peter D.R; Chaparro, Maria; Ben-Horin, Shomron |
| 2011 | The efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab | Kopylov, Uri; Mantzaris, Gerassimos J.; Katsanos, Konstantinos H.; Reenaers, Cathérine; Ellul, Pierre; Rahier, Jean-François; Israeli, Eran; Lakatos, Péter László; Fiorino, Gionata; Cesarini, Monica; Tsianos, Epameinondas V.; Louis, Édouard; Ben-Horin, Shomron |
| 2013 | Risk factors for osteoporosis in Crohn’s Disease : infliximab, corticosteroids, body mass index, and age of onset | Azzopardi, Neville; Ellul, Pierre |
